APA (7th ed.) Citation

Pavel A. Solopov, Ruben Manuel Luciano Colunga Biancatelli, Christiana Dimitropolou, Tierney Day, John D. Catravas, & John D. Catravas. (2022). Optimizing antidotal treatment with the oral HSP90 inhibitor TAS-116 against hydrochloric acid-induced pulmonary fibrosis in mice. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Pavel A. Solopov, Ruben Manuel Luciano Colunga Biancatelli, Christiana Dimitropolou, Tierney Day, John D. Catravas, and John D. Catravas. Optimizing Antidotal Treatment with the Oral HSP90 Inhibitor TAS-116 Against Hydrochloric Acid-induced Pulmonary Fibrosis in Mice. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Pavel A. Solopov, et al. Optimizing Antidotal Treatment with the Oral HSP90 Inhibitor TAS-116 Against Hydrochloric Acid-induced Pulmonary Fibrosis in Mice. Frontiers Media S.A., 2022.